Menu
Published: 14 Jan 2022 572 views
This project will develop and test new gold-based compounds as alternatives to current ovarian cancer chemotherapies.
Scholarship will fund a 3 year PhD candidature to work in the Chemistry Department of the RMIT School of Science CAMIC Laboratory. Project is a collaboration with immunologists (SHBS) to test gold-compounds as anti-ovarian cancer therapeutics.
RMIT University (officially Royal Melbourne Institute of Technology, informally RMIT) is an Australian public research university based in Melbourne, Victoria. Founded in 1887 as the Working Men's College of Melbourne by Francis Ormond, it initially opened as a private night school offering instruction in art, science and technology in response to the industrial revolution in Australia. It was made a public university by act of the Parliament of Victoria in 1992 after merging with the Phillip Institute of Technology. A dual sector institute, its enrolment of 320 trades students in 1887 ... continue reading
| Application Deadline | 01 Mar 2022 |
| School to study | RMIT University |
| Type | PhD |
| Sponsor | RMIT University |
| Gender | Men and Women |
Applicants need to have a background in synthetic organometallic chemistry using air sensitive technologies and some interest in medicinal chemistry. They must have completed a relevant Bachelor’s Degree and Honour’s or Master’s in synthetic inorganic chemistry/medicinal/pharmacology. Due to COVID-19 restrictions, applicants living in Australia at time of application will be preferred
Email Dr Ruchika Ojha and Distinguished Professor Suresh Bhargava ([email protected]) directly with their statement of interest, cover letter addressing the desirable criteria, CV and academic qualifications.
For more details, visit RMIT University website.